Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 8
2005 1
2006 5
2008 1
2009 1
2010 3
2011 1
2012 2
2013 2
2014 1
2015 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Metabolic alterations and targeted therapies in prostate cancer.
Flavin R, Zadra G, Loda M. Flavin R, et al. J Pathol. 2011 Jan;223(2):283-94. doi: 10.1002/path.2809. Epub 2010 Nov 16. J Pathol. 2011. PMID: 21125681 Free PMC article. Review.
Molecular genetics of human prostate cancer.
Rubin MA, De Marzo AM. Rubin MA, et al. Mod Pathol. 2004 Mar;17(3):380-8. doi: 10.1038/modpathol.3800051. Mod Pathol. 2004. PMID: 14752525 Free article. Review.
Effect of finasteride on risk of prostate cancer: how little we really know.
Rubin MA, Kantoff PW. Rubin MA, et al. J Cell Biochem. 2004 Feb 15;91(3):478-82. doi: 10.1002/jcb.10787. J Cell Biochem. 2004. PMID: 14755678 Review.
Are findings from studies of obesity and prostate cancer really in conflict?
Freedland SJ, Giovannucci E, Platz EA. Freedland SJ, et al. Cancer Causes Control. 2006 Feb;17(1):5-9. doi: 10.1007/s10552-005-0378-3. Cancer Causes Control. 2006. PMID: 16411047 Review.
Prognostic factors in lymph node-positive prostate cancer.
Hofer MD, Kuefer R, Huang W, Li H, Bismar TA, Perner S, Hautmann RE, Sanda MG, Gschwend JE, Rubin MA. Hofer MD, et al. Urology. 2006 May;67(5):1016-21. doi: 10.1016/j.urology.2005.10.055. Urology. 2006. PMID: 16698361
The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation.
Liu Z, Zanata SM, Kim J, Peterson MA, Di Vizio D, Chirieac LR, Pyne S, Agostini M, Freeman MR, Loda M. Liu Z, et al. Oncogene. 2013 Mar 28;32(13):1660-9. doi: 10.1038/onc.2012.188. Epub 2012 Jun 18. Oncogene. 2013. PMID: 22710717 Free PMC article.
Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
Crowe FL, Appleby PN, Travis RC, Barnett M, Brasky TM, Bueno-de-Mesquita HB, Chajes V, Chavarro JE, Chirlaque MD, English DR, Gibson RA, Giles GG, Goodman GE, Henning SM, Kaaks R, King IB, Kolonel LN, Kristal AR, Neuhouser ML, Park SY, Severi G, Siddiq A, Stampfer MJ, Stattin P, Tangen CM, TjĂžnneland A, Trichopoulos D, Tumino R, Wilkens LR, Key TJ, Allen NE; Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group. Crowe FL, et al. J Natl Cancer Inst. 2014 Sep 10;106(9):dju240. doi: 10.1093/jnci/dju240. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25210201 Free PMC article.
Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
Tyekucheva S, Martin NE, Stack EC, Wei W, Vathipadiekal V, Waldron L, Fiorentino M, Lis RT, Stampfer MJ, Loda M, Parmigiani G, Mucci LA, Birrer M. Tyekucheva S, et al. J Mol Diagn. 2015 Jul;17(4):374-81. doi: 10.1016/j.jmoldx.2015.02.002. Epub 2015 Apr 30. J Mol Diagn. 2015. PMID: 25937617 Free PMC article.
Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality.
Yang M, Kenfield SA, Van Blarigan EL, Wilson KM, Batista JL, Sesso HD, Ma J, Stampfer MJ, Chavarro JE. Yang M, et al. Int J Cancer. 2015 Nov 15;137(10):2462-9. doi: 10.1002/ijc.29608. Epub 2015 Jun 3. Int J Cancer. 2015. PMID: 25989745 Free PMC article.
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.
Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, Marani M, Strano S, Muti P, Blandino G, Loda M. Benassi B, et al. Cancer Discov. 2012 Mar;2(3):236-47. doi: 10.1158/2159-8290.CD-11-0219. Epub 2012 Jan 5. Cancer Discov. 2012. PMID: 22585994 Free PMC article.
25 results
Jump to page